In a nutshell This study aimed to compare the effectiveness and safety of endocrine therapy (ET) or chemotherapy (CT) before surgery in patients with invasive ductal carcinoma (IDC) of the breast that is hormone receptor (HR) positive (+) and human epidermal growth factor receptor 2 (ERBB2) negative (-). The study concluded CT before...
Read MoreBreast cancer Posts on Medivizor
Comparing the safety and effectiveness of pyrotinib versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer
In a nutshell This study compared the safety and effectiveness of pyrotinib (SHR-1258) plus capecitabine (Xeloda) versus lapatinib (Tyverb) plus capecitabine in patients with metastatic human epidermal growth factor (HER2)-positive breast cancer (BC) after previous treatment with trastuzumab (Herceptin) and chemotherapy. The data...
Read MoreReal-world outcomes of fulvestrant as first-line treatment of postmenopausal women with advanced breast cancer.
In a nutshell This study investigated the effectiveness of fulvestrant (Faslodex) as a first-line treatment for postmenopausal women with estrogen receptor-positive (ER+) metastatic breast cancer (BC) in a real-world setting. The data showed that the outcomes of these patients in the real-world setting were similar to clinical trials...
Read MoreCan trastuzumab improve the outcomes of women with HER2 positive breast cancer?
In a nutshell This study explored whether trastuzumab (Herceptin) is an efficient drug for the treatment of HER2-positive breast cancer (BC) in patients who have previously received radiotherapy (RT) after breast removal surgery. The authors found that trastuzumab reduced the recurrence of BC and improved survival without cancer coming...
Read MoreEvaluating the final effectiveness and safety outcomes of neratinib in patients with early stage HER2+/HR+ breast cancer.
In a nutshell This study reported the final effectiveness and safety outcomes of neratinib treatment in patients with early-stage HER2+/HR+ breast cancer. The data showed that neratinib significantly improved invasive disease-free survival in these patients who initiated treatment within 1 year of trastuzumab-based therapy. Some background...
Read MoreComparing the long-term effectiveness of integrated IMRT vs segmented 3D-CRT after modified breast removal surgery in breast cancer patients
In a nutshell This study compared the long-term effectiveness of integrated intensity-modulated radiation therapy (IMRT) and segmented 3D-conventional radiotherapy (3D-CRT) following breast-removal surgery (radical mastectomy) in patients with breast cancer (BC). The data showed that integrated IMRT reduced the recurrence rate in the long-term with...
Read MoreCan abemaciclib plus hormonal therapy be considered a safe and effective treatment in older patients with advanced breast cancer?
In a nutshell This article looked at the safety and effectiveness of abemaciclib (Verzenios) plus hormonal therapy (HT) in older patients with hormone receptor-positive (HR+)/HER-2 negative (HER2-) advanced breast cancer (BC). The authors concluded that abemaciclib + HT was effective across all age groups and while higher rates of side effects...
Read MoreEvaluating the best timing of surgery after chemotherapy in patients with breast cancer
In a nutshell This study evaluated the impact of different times after chemotherapy until breast cancer surgery on complications after surgery and survival outcomes. The data showed the optimal time to surgery (TTS) was between 21 and 28 days after chemotherapy in these patients. Some background Breast cancer (BC) is one of...
Read MoreIs pembrolizumab effective in treating triple negative breast cancer?
In a nutshell This article looked at several clinical trials to assess the safety of pembrolizumab (Keytruda) in patients with triple-negative breast cancer (TNBC). The authors found that pembrolizumab had an acceptable safety profile and was effective in treating all stages of TNBC. Some background Breast cancer (BC) is one of the most common...
Read MoreDoes removal of the breast tumor improve survival in stage IV breast cancer with bone metastasis?
In a nutshell This study investigated the effects of the removal of the breast tumor in patients newly diagnosed with stage IV breast cancer and bone metastasis only. The data showed that removal of the breast tumor improved survival outcomes and decreased the recurrence rates in these patients. Some background In stage IV breast cancer (BC), the...
Read MoreCan intraoperative radiotherapy be used to treat early-stage breast cancer?
In a nutshell This article looked at 5-year outcomes of intraoperative radiation therapy (IORT) for breast cancer (BC). The authors found that IORT may have a higher rate of cancer return compared to whole-breast radiation therapy (WBRT). Some background BC is one of the most common forms of cancer found in women. Standard care for BC is usually a...
Read MoreCan physical activity improve sleep quality in breast cancer survivors?
In a nutshell This article looked at the use of physical activity (PA) in improving sleep problems in breast cancer (BC) survivors. The authors found that PA may be effective in improving sleep quality in BC survivors. Some background Sleep is essential for good health. Sleep problems affect physical and emotional health. Sleep also affects...
Read More